Adiutrix Therapeutics, Inc.
New York, NY
- UEI
- SECASJ6KJBY5
- CAGE
- 9REA9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 79 Washington Pl #4f, New York, NY 10011, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen… | National Heart Lung and Blood Institute (NIH) | $3,507,903 |
Quick answers
Is Adiutrix Therapeutics, Inc. registered in SAM.gov?
Yes. Adiutrix Therapeutics, Inc.'s SAM.gov registration is active through September 18, 2027.
What is Adiutrix Therapeutics, Inc.'s most recent federal award?
Adiutrix Therapeutics, Inc.'s most recent federal grant award is Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen… (R42HL176297), from National Heart Lung and Blood Institute (NIH), on September 17, 2024.
On GovTribe
See Adiutrix Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors